Positive Results for Viromed VAP Therapy
Viromed Medical AG is reporting positive results for its PulmoPlas therapy in the treatment of ventilator-associated pneumonia (VAP) in intensive care unit patients.
Tag: ventilator-associated event
All
Latest
Positive Results for Viromed VAP Therapy
Viromed Medical AG is reporting positive results for its PulmoPlas therapy in the treatment of ventilator-associated pneumonia (VAP) in intensive care unit patients.
Read More
Zinc Deficiency Fuels Bacterial Pneumonia Risk
Zinc deficiency may raise the risk of infection by Acinetobacter baumannii, a leading cause of ventilator-associated pneumonia, according to new research.
Read More
Pneumonia: Etiology, Care and Prevention
Pneumonia is a potentially life-threatening infection of the lungs that inflames alveoli and spurs the overproduction of purulent material. Typically afflicting neonates and seniors, the COVID pandemic has revealed the importance of proper pneumonia care for all patients.
Read More
Enzyme-Antibiotic Combo May Combat Ventilator-associated Pneumonia
A new model shows that combining antibiotics with enzymes improved the removal of tough biofilms in VAP, a finding that could lead to more effective treatments.
Read More
ReddyPort Releases 24-hour NIV Oral Care Kit
ReddyPort has released a 24-hour NIV Oral Care Kit, with a new soft-pack design enhanced to meet the special clinical needs of noninvasive ventilation patients.
Read More
Innoviva’s Bacterial Pneumonia Treatment Secures FDA Approval
Xacduro was approved for intravenous use in patients 18 years of age and older for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex.
Read MoreOn-demand Webinar: Preventing VAE & Ventilator-Associated Pneumonia
RT Magazine’s webinar on reducing and preventing ventilator-associated events and pneumonia (VAE/VAP) is now available for on-demand viewing.
Read More
Additional Patent for ReddyPort NIV Oral Care Solutions
The US Patent Office issued US Patent No 11,324,910 to ReddyPort Inc to cover its positive pressure ventilation appliance modules and related systems and methods, the company reports.
Read More
RT 2022 May-June: The Digital Edition
In RT’s May-June 2022 issue, we cover the role respiratory therapists can play in lung ultrasound; high-flow oxygen for critical care COVID-19; and successful strategies for reducing VAE/VAP/HAP in the ICU.
Read More
Bactiguard’s Endotracheal Tube Reduced Ventilator-associated Pneumonia
A study published in the Annals of Intensive Care shows a 53% reduction of ventilator-associated pneumonia with Bactiguard’s endotracheal tube.
Read More
Alabama Hospital Adds ReddyPort Elbow, NIV Oral Care Solutions
Jackson Hospital (Montgomery, AL) selected ReddyPort Elbow in combination with ReddyPort NIV Maintenance products for patients on NIV without mask removal or interruption of CPAP or bi-level therapy.
Read More
Automated Surveillance for VAEs More Accurate, Curtails Human Error
A study showed that an automated system that uses an algorithm to detect ventilator-associated...
Read More
Preventing Ventilator-associated Lung Injury
Ventilator-associated lung injury (VALI), an acute lung injury that can develop during mechanical ventilation, increases complications and mortality risk in the intensive care unit.
Read More
RT On-demand Webinar: Reducing & Preventing VAE/VAP
Join RT Magazine on Sept 24th at 2pm ET for a free webinar on reducing and preventing VAE/VAP. Five experts in respiratory care and infectious disease control will discuss research and offer effective and successful strategies.
Read More
Intubation and VAP: A Complex Condition Requires Bundled Solutions
Clinicians and manufacturers are looking to a combination of technology, research, and best practices to fight ventilator-associated pneumonia, which, despite progress, continues to afflict thousands of patients every year.
Read More
New Strategies for Preventing VAP in Children
Researchers have developed a bundled prevention protocol for support of infants and children receiving mechanical ventilation in order to prevent VAP, the second most common hospital-associated infection in pediatric ICUs.
Read More
Residual Gastric Volume May Not Indicate VAP Risk
French researchers could not link the absence of monitoring stomach fluid volume and increased risk of pneumonia.
Read More
Ventilator-associated Pneumonia: They’ve Zapped VAP
At a community hospital in Indianapolis, strict adherence to protocols resulted in zero incidents of ventilator-associated pneumonia (VAP).
Read More